Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market
You're going to hear a lot about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.
It'll be co-promoted by Searle and Pfizer.
Celebrex is approved for osteo- and rheumatoid arthritis. It's as effective as other NSAIDs for joint pain and swelling.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote